Predictions
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.76
30.09.22
30.09.22
-
30.09.23
30.09.23
39.41%
03.10.22
03.10.22
Risky Investment
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€66.50
30.09.22
30.09.22
€120.00
31.12.24
31.12.24
324.36%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€13.70
30.09.22
30.09.22
€9.00
31.01.23
31.01.23
-12.08%
03.01.23
03.01.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€69.48
29.09.22
29.09.22
€80.00
31.12.24
31.12.24
17.30%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
scPharmaceuticals
Start price
Target price
Perf. (%)
€6.15
29.09.22
29.09.22
€8.00
31.12.24
31.12.24
-23.25%
10.10.22
10.10.22
Could be very worthwhile Investment >20% year
Prothena Corp. plc
Start price
Target price
Perf. (%)
€54.86
28.09.22
28.09.22
-
28.09.23
28.09.23
12.14%
01.10.22
01.10.22
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.16
27.09.22
27.09.22
-
27.09.23
27.09.23
-4.31%
01.10.22
01.10.22
Risky Investment
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.41
27.09.22
27.09.22
€11.60
27.09.23
27.09.23
8.69%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.29
27.09.22
27.09.22
-
27.09.23
27.09.23
26.64%
01.10.22
01.10.22
Risky Investment
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€27.00
25.09.22
25.09.22
€16.00
31.12.24
31.12.24
57.78%
01.11.22
01.11.22
Could be very worthwhile Investment >20% year
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€15.08
21.09.22
21.09.22
-
21.09.23
21.09.23
-4.44%
01.10.22
01.10.22
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€16.65
20.09.22
20.09.22
€32.00
31.01.23
31.01.23
-17.72%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.64
19.09.22
19.09.22
€17.00
19.09.23
19.09.23
-34.41%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.21
19.09.22
19.09.22
-
19.09.23
19.09.23
-12.19%
01.10.22
01.10.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Vivani Medical Inc.
Start price
Target price
Perf. (%)
€2.81
19.09.22
19.09.22
-
19.09.23
19.09.23
-67.84%
24.04.23
24.04.23
Probably not worthwhile Investment
Athersys Inc.
Start price
Target price
Perf. (%)
€1.87
19.09.22
19.09.22
€3.80
19.09.23
19.09.23
0.19%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€16.96
18.09.22
18.09.22
-
18.09.23
18.09.23
144.16%
18.05.23
18.05.23
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€17.43
18.09.22
18.09.22
-
18.09.23
18.09.23
-17.30%
01.10.22
01.10.22
Risky Investment
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.40
15.09.22
15.09.22
€8.00
15.09.23
15.09.23
-1.52%
17.09.22
17.09.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.40
15.09.22
15.09.22
€11.00
15.09.23
15.09.23
-1.52%
17.09.22
17.09.22
Differentiated customer and product portfolio
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
Athersys Inc.
Start price
Target price
Perf. (%)
€2.21
15.09.22
15.09.22
€4.60
15.09.23
15.09.23
-15.60%
19.09.22
19.09.22
Could be very worthwhile Investment >20% year